Summary. A method to measure the absolute values of the rate of cholesterol synthesis in vivo in the organs of the rat has been described. Adult male rats were intravenously infused for 3.5, 6 and 10 h with sodium 1-14 (C)-acetate and the specific activity of expired C0 2 was recorded during the experiment. Sterol radioactivities were measured in plasma, lipoproteins and in various organs, the radioactivities in each organ being corrected for cholesterol transfer. The rate of cholesterol synthesis in the intact rat and in each organ was calculated from the radioactivities of the sterols synthesized, that of the acetyl CoA metabolized and the rate of acetyl CoA utilization. The validity of the calculation has been discussed. The results showed that the intestine was the major site of cholesterol biosynthesis (about 50 p. 100).
Summary. A method to measure the absolute values of the rate of cholesterol synthesis in vivo in the organs of the rat has been described. Adult male rats were intravenously infused for 3.5, 6 and 10 h with sodium 1-14 (C)-acetate and the specific activity of expired C0 2 was recorded during the experiment. Sterol radioactivities were measured in plasma, lipoproteins and in various organs, the radioactivities in each organ being corrected for cholesterol transfer. The rate of cholesterol synthesis in the intact rat and in each organ was calculated from the radioactivities of the sterols synthesized, that of the acetyl CoA metabolized and the rate of acetyl CoA utilization. The validity of the calculation has been discussed. The results showed that the intestine was the major site of cholesterol biosynthesis (about 50 p. 100). The participation of other tissues, such as skin (20 p. 100), liver (less than 10 p. 100), kidneys, bone marrow, colon and stomach (2-3 p. 100), was less important, whereas that of all the other organs, particularly the adrenals, was very slight (0.2-1 p.100).
Introduction.
The rate of cholesterol synthesis in various tissues has been previously reported. Measurement in vitro (Dietschy and Siperstein, 1967 ; Dietschy and Wilson, 1968 ; Srere et al., 1950) probably led to erroneous results since naturally occurring regulatory mechanisms were suppressed in those conditions (Chevallier and Math6, 1976) . On the other hand, during experiments in vivo the measurement of labeled precursor incorporation into sterols (Jansen et al.,1970 ; Popjak and Beeckmans, 1950 ; Schwenk et at., 1955 ; Van Bruggen et al., 1953) , without estimating the contribution of cholesterol transfer between the plasma and the organs to the labeling, may have also resulted in some cases in erroneous values. In these conditions, the liver was generally believed to be the major source of cholesterol biosynthesis (Kritchevsky, 1958) .
Permanent cholesterol transfer between the plasma and the organs, and viceversa, explains why a part of organ cholesterol comes from the plasma and the cholesterol synthesized in situ in the organs is released into the plasma. Thus, organ cholesterol has a double origin : in situ synthesis and the plasma. Generally, most of the organ cholesterol is of plasmatic origin (Chevallier, 1967 (fig. 3 ). The measured equilibrium value was proportional to the rate of infused radioactivity. An equilibrium value of 1 ¡ L Ci/1 p. 100 CO 2 was obtained by 1-14 (C)-acetate infusion at a mean rate of 24.4 ! 2.0 ¡ L Ci/h. Since that acetate infusion rate was variable in the different experiments, the crude radioactivities were corrected to the above specific equilibrium activity of 14 C0 2 . Under these conditions, the administered activities (R o -t ) were 188 ! 22.10 6 , 322 ± 37.10 6 and 537 ! 62.10 6 dpm for 3.5, 6 and 10-hour infusion times, respectively.
2. -Cholesterol radioactivity and specific activity in the organs, plasma and intact animal.
Specific activities of free and esterified plasma cholesterol increased with time ( fig. 4) (Giraud-D'Hollander et al., 1976) . Therefore, in the liver, the contribution of transferred cholesterol was largely underestimated. If, for transfer correction, the specific activity of free cholesterol of the VLDL is used instead of that of the plasma, the participation of the liver
